MEDP — Medpace Holdings, Inc.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1668397 ·
Last close
$601.38
Market Cap
$16.78B
52W High
$677.90
52W Low
$402.43
ADV30
358,297
Next earnings
2026-10-19
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 706,604,000 | 196,326,000 | 141,503,000 | 123,870,000 | 2,129,613,000 | 652,681,000 | 1,531,299,000 |
| Dec 2025 | 708,450,000 | 205,316,000 | 153,269,000 | 135,133,000 | 1,975,472,000 | 497,049,000 | 1,516,401,000 |
| Sep 2025 | 659,903,000 | 196,939,000 | 141,808,000 | 111,135,000 | 1,753,012,000 | 285,351,000 | 1,459,371,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$739,175,000
Investing CF
$-27,901,000
Financing CF
$-501,752,000
CapEx
$-28,176,000
Dividends Paid
—
Buybacks
$-545,489,000
EPS Diluted TTM
$15.91
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-336,111,000
Inventory
—
Receivables
$394,581,000
ST Investments
—
EBIT TTM
$562,915,000
Pretax Income TTM
$571,798,000
Interest Exp TTM
—
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,782,287,872
EBITDA
$611,200,000
Free Cash Flow
$547,985,472
Enterprise Value
$16,526,215,168
Total Cash
$502,688,000
Total Debt
$120,100,000
Shares Out
27,910,605
Trailing EPS
$18.24
Book Value
$16.18
ROE
162.2%
ROA
20.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,530,234,000 | 534,935,000 | 451,123,000 | 1,975,472,000 | 1,516,401,000 | — | 713,223,000 |
| Dec 2024 | 2,109,054,000 | 446,870,000 | 404,386,000 | 2,100,866,000 | 1,275,321,000 | — | 608,815,000 |
| Dec 2023 | 1,885,842,000 | 336,825,000 | 282,810,000 | 1,656,828,000 | 1,097,878,000 | — | 433,374,000 |
| Dec 2022 | 1,459,996,000 | 278,697,000 | 245,368,000 | 1,352,495,000 | 966,108,000 | — | 388,050,000 |
TTM Snapshot
Revenues TTM
$1,705,127,000
NetIncome TTM
$281,577,000
OpCashFlow TTM
$0
Assets (Latest)
$2,100,866,000
Forward EPS
$18.78
Max Pain — expiry 2026-12-18
max pain strike: $570.00 · spot: $601.38 · call oi: 219 · put oi: 2,054
Expected Move to 2026-12-18:
±$219.40
(36.48%) —
implied range
$381.98 –
$820.78
· ATM straddle on $600.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ICLR | ICON PLC | $12.79B | $165.76 | — |
| INCY | INCYTE CORP | $23.51B | $117.67 | — |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $10.91B | $226.58 | — |
| IQV | IQVIA HOLDINGS INC. | $34.72B | $208.05 | — |
| LNTH | Lantheus Holdings, Inc. | $6.82B | $104.82 | — |
News headlines (Yahoo Finance, 1h cache)
Why Medpace Holdings (MEDP) Is Up 11.8% After Raising 2026 Guidance And Expanding Backlog
2026-07-25 08:13 · Yahoo
Medpace Holdings, Inc. (MEDP) Hit a 52 Week High, Can the Run Continue?
2026-07-24 13:15 · Yahoo
2 Momentum Stocks with Exciting Potential and 1 We Question
2026-07-24 08:49 · Yahoo
Medpace Holdings Inc (MEDP) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Record ...
2026-07-23 21:00 · Yahoo
Medpace Notches A Big Bookings Beat, And Reverses Its First-Quarter Malaise
2026-07-23 20:18 · Yahoo
The 'Standout Performance' That Could Save Thermo Fisher, Danaher And Others
2026-07-23 20:18 · Yahoo
Why Is Medpace (MEDP) Stock Soaring Today
2026-07-23 17:48 · Yahoo
Medpace Q2 Earnings Call Highlights
2026-07-23 15:07 · Yahoo
Medpace (MEDP) Beats Q2 Earnings and Revenue Estimates
2026-07-22 21:55 · Yahoo
Medpace (NASDAQ:MEDP) Exceeds Q2 CY2026 Expectations, Stock Jumps 18.6%
2026-07-22 20:59 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.